…
…
World
Herz — World Desk · · 30s summary · 2 min read
On World Hepatitis Day, July 28, 2026, the World Health Organization (WHO) is calling for strengthened research, screening, treatment access, and political commitment in the fight against hepatitis B and C. According to the WHO, 287 million people worldwide currently live with chronic hepatitis B or C. Hepatitis B alone is responsible for 1.1 million deaths annually—more than double the death toll from malaria. Despite curative treatments being available since 2015, only approximately 20% of hepatitis C patients have received treatment. A major breakthrough occurred in spring 2026, when Chinese researchers achieved the first functional cure of hepatitis B.
On World Hepatitis Day, July 28, 2026, the World Health Organization (WHO) is calling for strengthened research, screening, treatment access, and political commitment in the fight against hepatitis B and C.
According to the WHO, 287 million people worldwide currently live with chronic hepatitis B or C.
Hepatitis B represents the heavier disease burden of the two. Approximately 240 million people are affected, and it causes 1.1 million deaths annually—more than double the mortality from malaria.
Hepatitis C causes approximately 240,000 deaths annually worldwide. Since 2015, the vast majority of cases are curable thanks to available treatments. Yet only about 20% of patients have received treatment since then, according to the WHO.
The illustrations in this article are generated by artificial intelligence.
No comments yet. Be the first to react.
The WHO recommends systematic screening for hepatitis B in all pregnant women, and immediate vaccination of newborns whose mothers are infected.
In Germany, the STIKO (Standing Committee on Vaccination, or Ständige Impfkommission) recommends hepatitis B vaccination from infancy, as well as for adults at particular risk due to certain medical conditions or high contagion risk.
In spring 2026, a team of Chinese researchers successfully achieved the first functional cure of hepatitis B in some patients—meaning viral load reduced below the detection threshold—through combined therapy.
Details of the combined therapy used by the Chinese team—number of study participants, molecules involved, durability of results—are not specified in available sources.
It is unclear whether these results have undergone independent validation or been published in a peer-reviewed journal.
According to the WHO, hepatitis B causes approximately 1.1 million deaths annually worldwide, more than double the deaths from malaria.
Yes: since 2015, the vast majority of hepatitis C cases can be cured. However, according to the WHO, only about 20% of patients have received treatment since that date.
In spring 2026, Chinese researchers achieved a functional cure—viral load reduced below the detection threshold—in some patients with chronic hepatitis B through combined therapy. This is a world first.
The WHO recommends systematic screening of all pregnant women for hepatitis B and immediate vaccination of newborns whose mothers are infected.